NPCE is currently covered by 5 analysts with an average price target of $16.13. This is a potential upside of $4.11 (34.19%) from yesterday's end of day stock price of $12.02.
Neuropace's activity chart (see below) currently has 83 price targets and 78 ratings on display. The stock rating distribution of NPCE is 100% BUY.
Analysts' price targets on this stock were met 67.37% of the time, taking 158.3 days on average.
Highest price target for NPCE is $22, Lowest price target is $7, average price target is $16.13.
Most recent stock forecast was given by MIKE KRATKY from LEERINK. First documented stock forecast 16-May-2021.
Currently out of the existing stock ratings of NPCE, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-May-2025
$7
$-5.02 (-41.76%)
$20
3 days ago
(12-Nov-2026)
Buy Since 16-May-2021
$9
$-3.02 (-25.12%)
$16
3 days ago
(12-Nov-2026)
Buy Since 28-May-2024
$9
$-3.02 (-25.12%)
$16
3 days ago
(12-Nov-2026)
Buy Since 27-May-2025
$20
$7.98 (66.39%)
$20
3 months 18 days ago
(28-Jul-2026)
2/4 (50%)
$6.36 (46.63%)
222
Buy Since 20-Jan-2025
$22
$9.98 (83.03%)
$22
10 months 2 days ago
(13-Jan-2026)
2/4 (50%)
$5.25 (31.34%)
221
What is NPCE (Neuropace) average time for price targets to be met?
Which analyst most recently updated their price target on NPCE (Neuropace)?
Which analyst has the most public recommendations on NPCE (Neuropace)?
Which analyst is the currently most bullish on NPCE (Neuropace)?
Which analyst is the currently most reserved on NPCE (Neuropace)?